论文部分内容阅读
目的:探讨奥扎格雷钠阿司匹林联合治疗急性脑梗死的临床疗效。方法:选取收治的急性脑梗死患者120例进行回顾性分析,随机分成观察组和对照组两组,每组60例,观察组采用奥扎格雷钠阿司匹林联合治疗,对照组仅采用阿司匹林治疗,观察两组在治疗效果和治疗前后神经功能缺损评分上的不同。结果:观察组治疗效果显著优于对照组,存在统计学意义(P<0.05);治疗前后神经功能缺损评分有显著变化,且观察组变化显著优于对照组,存在统计学意义(P<0.05)。结论:奥扎格雷钠阿司匹林联合治疗急性脑梗死效果显著,能够有效控制纤维蛋白原水平,改善神经功能,值得临床推广。
Objective: To investigate the clinical efficacy of ozagrel sodium aspirin in the treatment of acute cerebral infarction. Methods: A total of 120 patients with acute cerebral infarction were selected for retrospective analysis. They were randomly divided into observation group and control group, 60 cases in each group. The observation group was treated with ozagrel sodium aspirin. The control group was treated with aspirin only. The two groups in the treatment of neurological deficits and treatment before and after the score on the difference. Results: The therapeutic effect of the observation group was significantly better than that of the control group (P <0.05), and the score of neurological deficits significantly changed before and after treatment, and the changes in the observation group were significantly better than those in the control group (P <0.05 ). Conclusion: The combination of ozagrel sodium and aspirin has a significant effect on acute cerebral infarction. It can effectively control fibrinogen level and improve neurological function, which is worthy of clinical promotion.